The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
4-fluoroisoquinolin-5-amine; CAS No.: 928664-14-6;4-fluoroisoquinolin-5-amine. PROPERTIES: 4-fluoroisoquinolin-5-amine is a halogenated heterocyclic amine with molecular formula C9H6FN2. This crystalline solid typically exhibits a pale yellow color and has a melting point ranging between 170-175 C. The compound demonstrates moderate solubility in polar organic solvents like methanol and dichloromethane while being sparingly soluble in water. The 4-fluoroisoquinolin-5-amine structure contains a highly reactive amine group positioned para to the fluorine substituent on the isoquinoline ring system. Proper storage requires a tightly sealed container in a desiccator with appropriate drying agents, maintained at temperatures below 5 C to prevent hydrolytic degradation. Safety precautions include using P290 respiratory protection and Nitrile gloves during handling, as the compound may cause respiratory irritation and skin sensitization. According to EU safety regulations, it carries H317 and H335 hazard statements for potential sensitization and respiratory tract irritation. APPLICATIONS: The 4-fluoroisoquinolin-5-amine molecule serves as a key intermediate in the synthesis of isoquinoline-based antibiotics, as reported in medicinal chemistry research focusing on antimicrobial agents. Its unique substitution pattern enables selective functionalization in peptide coupling reactions, making it valuable for creating bioactive conjugates. Additionally, 4-fluoroisoquinolin-5-amine derivatives have been investigated for their fluorescent properties in chemical sensing applications, as described in analytical chemistry literature. The compound's ability to participate in hydrogen bonding interactions makes it particularly useful in designing molecules with optimized bioavailability, as discussed in pharmaceutical formulation studies emphasizing drug delivery systems.